These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9687402)

  • 41. In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.
    Janoir C; Podglajen I; Kitzis MD; Poyart C; Gutmann L
    J Infect Dis; 1999 Aug; 180(2):555-8. PubMed ID: 10395882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae.
    Zhanel GG; James J; Derkatch S; Laing N; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2006 Jul; 58(1):112-6. PubMed ID: 16644764
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoroquinolones: is there a different mechanism of action and resistance against Streptococcus pneumoniae?
    Harding I; Simpson I
    J Chemother; 2000 Oct; 12 Suppl 4():7-15. PubMed ID: 11131958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
    Korzheva N; Davies TA; Goldschmidt R
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2479-86. PubMed ID: 15917550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004-2005 to 2014-2015.
    Schmitz J; van der Linden M; Al-Lahham A; Levina N; Pletz MW; Imöhl M
    Int J Med Microbiol; 2017 Jun; 307(4-5):216-222. PubMed ID: 28506425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.
    Adam HJ; Schurek KN; Nichol KA; Hoban CJ; Baudry TJ; Laing NM; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2007 Jan; 51(1):198-207. PubMed ID: 17088485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.
    Richardson DC; Bast D; McGeer A; Low DE
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1911-4. PubMed ID: 11353652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS; Yague G; Fisher LM
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin.
    Brenwald NP; Gill MJ; Wise R
    J Antimicrob Chemother; 1997 Sep; 40(3):458-60. PubMed ID: 9338508
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence for active drug efflux in fluoroquinolone resistance in Clostridium hathewayi.
    Rafii F; Park M; Wynne R
    Chemotherapy; 2005 Aug; 51(5):256-62. PubMed ID: 16088123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
    Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
    Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis.
    Oyamada Y; Ito H; Inoue M; Yamagishi JI
    J Med Microbiol; 2006 Oct; 55(Pt 10):1395-1401. PubMed ID: 17005789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.
    Pestova E; Millichap JJ; Noskin GA; Peterson LR
    J Antimicrob Chemother; 2000 May; 45(5):583-90. PubMed ID: 10797078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes.
    Godreuil S; Galimand M; Gerbaud G; Jacquet C; Courvalin P
    Antimicrob Agents Chemother; 2003 Feb; 47(2):704-8. PubMed ID: 12543681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae.
    Jumbe NL; Louie A; Miller MH; Liu W; Deziel MR; Tam VH; Bachhawat R; Drusano GL
    Antimicrob Agents Chemother; 2006 Jan; 50(1):310-7. PubMed ID: 16377702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.
    Raherison S; Gonzalez P; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Mar; 46(3):672-9. PubMed ID: 11850247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine.
    Markham PN
    Antimicrob Agents Chemother; 1999 Apr; 43(4):988-9. PubMed ID: 10103220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.
    Reinert RR; Al-Lahham A; Lütticken R; Boos M; Schmitz FJ
    J Antimicrob Chemother; 2002 Jun; 49(6):1015-8. PubMed ID: 12039895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).
    Davies TA; Goldschmidt R; Pfleger S; Loeloff M; Bush K; Sahm DF; Evangelista A
    J Antimicrob Chemother; 2003 Aug; 52(2):168-75. PubMed ID: 12837740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The molecular epidemiology of Streptococcus pneumoniae with quinolone resistance mutations.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Rice CL; Doern GV
    Clin Infect Dis; 2005 Jan; 40(2):225-35. PubMed ID: 15655739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.